Anne-Marie Malfait to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Anne-Marie Malfait has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.293
-
Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety. Pain. 2019 10; 160(10):2210-2220.
Score: 0.160
-
Nerve growth factor blockade for the management of osteoarthritis pain: what can we learn from clinical trials and preclinical models? Curr Opin Rheumatol. 2017 01; 29(1):110-118.
Score: 0.133